FDA Says It’s Eliminating Requirements for Generic Versions of Expensive Drugs

‘We’re cutting unnecessary red tape,’ Health Secretary Robert F. Kennedy Jr. said.

The U.S. Food and Drug Administration (FDA) in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times

Health officials announced on Oct. 29 that they are proposing the elimination of testing requirements for biosimilars, or generic versions of biologic drugs.

The Food and Drug Administration in draft guidance said it will reduce instances where large human trials are required for biosimilars.